Journal of Otology & RhinologyISSN: 2324-8785

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
bahis siteleri bahis siteleri bahis siteleri casino siteleri

MPNST ex. Diffuse Neurofibroma in a Patient with Unknown History of NF1, A Case Report


Mahmoud A Ebrahim, Khaled M Hindi, Mishal M. AlMutairi and Jassem M Bastaki

Al-Sabah Hospital, Kuwait

KIMS, Kuwait

Zain Hospital, Kuwait

Al-Sabah Hospital, Kuwait

: J Otol Rhinol

Abstract


Malignant peripheral nerve sheath tumor (MPNST) is defined as spindle cell sarcomas arising from or differentiating towards the cells of the peripheral nerve sheath. MPNST is extremely rare in the parotid gland and, in most cases, the prognosis is grim. It usually develops in the setting of Neurofibromatosis type-1 (NF1), but can also develop sporadically. Herein, we report a rare case of MPNST of the parotid gland, in a patient with no previous history of NF1. A 45 years old patient presented with a non-tender right parotid swelling of one-year duration. A sudden increase in the size of the parotid mass over the past two months alerted the surgeon to proceed to investigate the nature of the mass and the etiology of the sudden change in size. The patient’s initial investigations, which included ultrasound imaging of the swelling, fine needle aspiration (FNA), Computed Tomography (CT) scan, and Magnetic Resonance Imaging (MRI) of the neck and swelling were consistent with a benign pleomorphic adenoma of the parotid gland. However, during the surgery the dissection was difficult and the tumor appeared adherent to the surrounding tissue, which lead to a total parotidectomy, in piecemeal! The histopathology revealed a low-grade spindle cell neoplasm exhibiting a diffuse, infiltrative growth pattern, invading into and around salivary lobules, adipose tissue, skeletal muscle bundles and fascia. The morphology and positive s100 & CD34 stains suggested diffuse neurofibroma. Scattered foci of epithelioid cells with increased pleomorphism and mitotic activity were also evident. The diagnosis rendered was thus MPNST of the parotid gland arising from a diffuse neurofibroma. The patient was also diagnosed with NF1 based on clinicopathologic correlation with a referral for confirmatory genetic testing. The patient underwent radiotherapy to continue his treatment following the resection of the tumor. References: 1. Chis, O., &Albu, S. (2014). Malignant Peripheral Nerve Sheath Tumor of the Parotid Gland. The Journal of Craniofacial Surgery, 25(5). 2. Imamura, S., Suzuki, H., Usami, S., Koda, E., &Yoshizawa, A. (2003). Malignant Peripheral Nerve Sheath Tumor of the Parotid Gland. Annals of Otology, Rhinology & Laryngology, 112(7), 637643 3. Biswa, P. (2012). Malignant Peripheral Nerve Sheath Tumor in Parotid Gland-A Rare and Challenging Case. Journal of Clinical Case Reports, 03(01). 4. Inoue, T., Kuwashiro, M., Misago, N., &Narisawa, Y. (2014). Superficial malignant peripheral nerve sheath tumor arising from diffuse neurofibroma in a neurofibromatosis type 1 patient. The Journal of Dermatology,41(7), 631-633. 5. De-Stefano, A., Kulamarva, G., Citraro, L., Borgia, L., & Croce, A. (2013). Malignant peripheral nerve sheath tumour (malignant epithelioidSchwannoma) of the parotid gland. Bratislava Medical Journal, 113(10), 628-631.

Biography


Mahmoud Ebrahim is a young doctor who just finished his internship year and has passion for otolaryngology and head and neck surgery. He is a hard working doctor at work who gives his maximum to the care of the patient’s and there well-being. Outside of work he devotes his time in research and publications and attending courses. He is currently working as an assistant registrar in general surgery and attending ENT electives, as he is building up and strengthening his CV to apply for residency outside his home country. ma7moud_ibrahim@hotmail.com

Track Your Manuscript

Awards Nomination

Media Partners

Associations

GET THE APP